# Dendritic Cell Vaccine for High Risk Ovarian Cancer Patients

> **NCT00478452** · PHASE1 · COMPLETED · sponsor: **University of Pennsylvania** · enrollment: 14 (actual)

## Conditions studied

- Ovarian Cancer
- Fallopian Tube Cancer
- Primary Peritoneal Carcinoma

## Interventions

- **BIOLOGICAL:** DC-Ova
- **BIOLOGICAL:** DC Ova with Cyclophosphamide

## Key facts

- **NCT ID:** NCT00478452
- **Lead sponsor:** University of Pennsylvania
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-08
- **Primary completion:** 2008-08
- **Final completion:** 2008-08
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2019-10-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00478452

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00478452, "Dendritic Cell Vaccine for High Risk Ovarian Cancer Patients". Retrieved via AI Analytics 2026-07-17 from https://api.ai-analytics.org/clinical/NCT00478452. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*